Navigation Links
BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
Date:8/20/2008

WOBURN, Mass., Aug. 20 /PRNewswire/ -- BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, today announced the UK Medicines and Healthcare products Regulatory Agency (MHRA) has accepted BioVex's Clinical Trial Application to conduct a Phase I clinical study testing the safety and immunogenicity of its lead infectious disease candidate for genital herpes, ImmunoVEX HSV2.

ImmunoVEX HSV2 is a novel live-attenuated vaccine which has been rationally designed to remove the genes that allow herpes virus to avoid the immune system. This should allow the immune system to recognize and mount a powerful immune response against the causative agent of genital herpes. In preclinical studies, ImmunoVEX HSV2 completely prevented all symptoms of genital herpes and triggered a powerful immune response, suggesting that ImmunoVEX HSV2 may be more potent than other HSV-2 vaccines for which data has been published.

BioVex's Founder and Chief Technology Officer, Dr. Robert Coffin, commented:

"Genital herpes is a significant and growing public health issue. All previous attempts to develop either a prophylactic or therapeutic vaccine have either failed or have shown efficacy in only a very limited proportion of the population. We believe that this vaccine, based on a new understanding of HSV biology, has the potential to substantially advance the field. Accordingly, today's news is a significant milestone towards realizing this potential."

About Genital Herpes

At least 45 million people over the age of 12 in the United States have been infected with HSV-2, the cause of genital herpes, according to the Centers for Disease Control and Prevention. There is currently no cure for genital herpes and the standard treatment protocol includes daily suppressive therapy and antiviral medications.

About BioVex

BioVex is a privately held biotechnology Company based in Woburn
'/>"/>

SOURCE BioVex Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
2. BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
3. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
4. AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
5. Clinical Trials Bootcamp Announces Inaugural Meeting
6. Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172
7. NewCardio Announces Positive Results From Third Clinical Validation Study
8. Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
9. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
10. Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
11. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 PuraMed BioScience ® , Inc., ... (OTC) medicinal and healthcare products, announced today that ... along with the name,s red and yellow logo. ... name MigraPure ®  going forward. The new ... natural migraine pain reliever will be reintroduced into ...
(Date:7/30/2014)... Research and Markets has announced the addition ... 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... at a lower CAGR in developed countries; however, it is expected ... China , India , and ... growth of the hematology analyzers and reagents market is driven by ...
(Date:7/30/2014)... , July 30, 2014  Today the US Surgeon ... and outdoor sun tanning or sun burns stating they can ... Surgeon, General Boris Lushniak , says that "skin cancer ... and that too much exposure to indoor and outdoor ultraviolet ... Dermatology and Aesthetic Medicine, in Boca Raton, Florida ...
Breaking Medicine Technology:PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Hematology Analyzers & Reagents Market - Forecasts to 2019 2Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2
(Date:7/30/2014)... 2014 Everyone knows that the internet is ... Whether people are looking for something to buy, trying to ... the internet is pretty much always going to be the ... Lauderdale Florida is so happy to announce the launch of ... into the modern age. Whether a person wants to know ...
(Date:7/30/2014)... 2014 “North America Contrast Media Injectors ... the North America Contrast Media Injectors market. The report ... (in units) and average price data (in US dollars), ...     Interventional Cardiology/Angio Injectors and MRI Injectors ... a substance used to enhance the contrast of structures ...
(Date:7/30/2014)... Association for Vedic Studies (WAVES) conference is coming to ... July 31 through Sunday, August 3. To watch the ... is the first time such a large and diverse ... campus to explore the relevance of ancient Vedic knowledge ... higher states of consciousness, and reflections on the various ...
(Date:7/30/2014)... Washington, DC (PRWEB) July 30, 2014 ... have recently joined the Board of Directors of ... provides guidance for the Association, which has a ... in healthcare delivery through telecommunications and information technology. ... members of the Association, possess extraordinary expertise and ...
(Date:7/30/2014)... global digital pathology market was valued at an estimated $250.2 ... CAGR of 11.8%, to reach an estimated $437 million by ... is expected to continue to rise in the coming years ... enable pathologists to be efficient and this leads to improved ... market was valued at $128.9 million and accounted for the ...
Breaking Medicine News(10 mins):Health News:Sierra Dental Releases New Website For Fort Lauderdale Residents 2Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 2Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 3Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 4Health News:Vedic living in a modern world: International conference at Maharishi University 2Health News:Vedic living in a modern world: International conference at Maharishi University 3Health News:American Telemedicine Association Welcomes Two New Members to the Board of Directors 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 4Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 5
... decided to launch a ban on sale of Colas and junk ... and junk food may be out of school canteens across the ... are bad for children’s health. Hence, we want to ban the ... with Union Human Resource Development Ministry on the legal aspects of ...
... cancer is available in Singapore for those between the ... ,The Health Sciences Authority (HSA) gave its approval ... similar vaccine, Cervarix, from competitor GlaxoSmithKline, is awaiting approval ... health breakthrough, said Tay Eng Hseon, a doctor at ...
... gas tragedy survivors' organisations claimed //to have seized a ... medical stores of the Bhopal Gas Tragedy Relief and ... organisations, working for the victims of the world's worst ... their expiry date," Rachna Dhingra of Bhopal Group of ...
... donated $30 million to University Hospitals (UH), a major ... turned his graduate thesis into a global automotive business ... himself, his wife Usha and their family, in support ... 2010. ,In recognition of the Ahuja family's ...
... treatment to remove lead from the body -- can significantly ... a// Cornell study of young rats finds. ,However, ... of autistic children, the researchers say that when rats with ... chemical, they showed declines in their learning and behavior that ...
... on women in their 70's to observe the relationship between ... followed nearly 12,000 women in// their 70’s over a 6 ... for 3-6 days/week, depending on alcoholic content) may lead to ... ,This study was published in Journal of the American ...
Cached Medicine News:Health News:Indian American Donates $30 Mn to Healthcare System 2Health News:Pros and Cons of Therapy for Lead Exposure 2
... The UST-9121 is an ... sector transducer with a wide ... frequencies, this transducer is designed ... an intercostal window. The versatility ...
... transducer is a curved ... the higher frequencies. Featuring ... this transducer provides exceptional ... frequency abdominal kidney bladder ...
... to Enzo Clinical Labs, a full service ... the leading regional labs in the country, ... of a large laboratory with the convenience ... Enzo was one of the area's first ...
... Test System* is a multiplexed, fluorescent, ... multiple assays from a single sample ... a simple and streamlined alternative to ... clinical sensitivity and comparable clinical specificity ...
Medicine Products: